Cystic fibrosis: triple therapy shows promising results
The triple therapy Trikafta (elexacaftor, tezacaftor, and ivacaftor) has the potential to lead to “transformative improvements in the lives of people with cystic fibrosis,” two phase III trials…
Read Original Article: Cystic fibrosis: triple therapy shows promising results »
